Clinical Trials › NCT06564311
Active, Not RecruitingPhase 2
A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone)
Sponsored by Zenas BioPharma (USA), LLC
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 93
Target enrollment
11
U.S. states
Aug 2024
Start date
Feb 2026
Expected completion
Interventions / Treatments
ObexelimabPlacebo
Conditions studied
Relapsing Multiple Sclerosis
Where this trial is running (14 sites)
Arizona2 sites
Phoenix · Scottsdale
Florida2 sites
Naples · Tampa
Wisconsin2 sites
Greenfield · Milwaukee
Alabama1 site
Cullman
California1 site
West Hollywood
Massachusetts1 site
Worcester
Minnesota1 site
Plymouth
Missouri1 site
St Louis
New Jersey1 site
Teaneck
Ohio1 site
Columbus
Texas1 site
Plano
Participating MS centers on MS Buddy (7)
Regina Berkovich MD PhD Inc MS Neurology
West Hollywood, CA
West Hollywood, CA
Center for Neurological Disorders
Greenfield, WI
Greenfield, WI
USF Multiple Sclerosis Center
Tampa, FL
Tampa, FL
Center for Neurology and Spine
Phoenix, AZ
Phoenix, AZ
MS centers in Arizona
Compare treatment centers near a trial site — patient experience, providers, and care ratings.
View Arizona centersMore Phase 2 trials
Browse all Phase 2 MS trialsCheck out the MS Buddy App
Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.
